Nagaraja Sridhar is a Nephrology physician affiliated with Buffalo Medical Group. OpenAlex indexes 24 publications with 323 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
85 High St
Buffalo, NY 142031149
Telephone
716-857-8607Provider last certified this registry record 14 Dec 2021.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Aurinia Pharma U.S., Inc.Program year20251 payment
- Travere Therapeutics, Inc.Program year20259 payments
- Travere Therapeutics, Inc.Program year202422 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
66.5%Calcium channel blocker12.8%Amlodipine Besylate74%Nifedipine Er14%Diltiazem 24hr Er (Cd)4%Verapamil Er2%Diltiazem 24hr Er (La)2%Verapamil Sr2%Diltiazem 24hr Er1%Verapamil Hcl1%Part D<11 patientsLoop diuretic8.8%Bumetanide50%Torsemide30%Furosemide20%Part D≥76 patients+ 19 more classes in this area
Metabolism & gastrointestinal
11.1%Corticosteroid1.9%Prednisone100%Part D≥33 patientsPotassium supplement1.6%Potassium Chloride82%Klor-Con18%Part D<11 patients+ 10 more classes in this area
Other
5.4%Phosphate Binder3.3%Sevelamer Carbonate88%Renvela7%Sevelamer Hcl5%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia1.8%Lokelma67%Velphoro33%Part D≥34 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of dialysate bicarbonate and sodium on blood pH in maintenance hemodialysis—A prospective study
Therapeutic Apheresis and Dialysis
2022 - A Clinical and Radiographic Evaluation of Periodontal Regenerative Potential of PerioGlas®: A Synthetic, Resorbable Material in Treating Periodontal Infrabony Defects.
PubMed
2014 - Radiotherapy of femoral chondrosarcoma in a Rottweiler
Indian Journal of Veterinary Surgery
2014 - Prevalence and severity of periodontal disease in type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus) patients in Bangalore city: An epidemiological study
Journal of Indian Society of Periodontology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Kathleen Bethin, MD
Buffalo Medical Group
Victor Yosuico, MD
Buffalo Medical Group
James Egnatchik, MD
Buffalo Medical Group
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”